Evidence map›Paper›PMID 31431817›Full record

ArticleBiomicrofluidics2019

On-chip immunofluorescence analysis of single cervical cells using an electroactive microwell array with barrier for cervical screening.

Makoto Takeuchi, Kazunori Nagasaka, Mina Yoshida, Yoshiko Kawata, Yuko Miyagawa, Saori Tago, Haruko Hiraike, Osamu Wada-Hiraike, Katsutoshi Oda, Yutaka Osuga and 4 more

Abstract read
In one paragraph

Article in Biomicrofluidics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Validation of an on-chip p16Scientific reports · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Makoto Takeuchi
Kazunori NagasakaDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo 173-8605, Japan.ORCID 0000-0002-0696-5175
Mina YoshidaInstitute of Industrial Science, University of Tokyo, Tokyo 153-8505, Japan.
Yoshiko KawataDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan.
Yuko MiyagawaDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo 173-8605, Japan.
Saori TagoInstitute of Industrial Science, University of Tokyo, Tokyo 153-8505, Japan.
Haruko HiraikeDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo 173-8605, Japan.
Osamu Wada-HiraikeDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo 173-8605, Japan.
Katsutoshi OdaDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan.
Yutaka OsugaDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan.
Tomoyuki FujiiDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Tokyo 113-8655, Japan.
Takuya AyabeDepartment of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo 173-8605, Japan.
Teruo FujiiInstitute of Industrial Science, University of Tokyo, Tokyo 153-8505, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several specific tests for cervical screening have been developed recently, including p16/Ki67 dual immunostaining for diagnosing high-risk human papillomavirus positive squamous intraepithelial lesion in the cervix. However, manual screening of cells in an entire glass slide is currently a standard clinical procedure for quantification and interpretation of immunocytochemical features of the cells. Here, we developed a microfluidic device containing an electroactive microwell array with barriers (EMAB) for highly efficient single-cell trapping followed by on-chip immunofluorescence analysis with minimum loss of the sample. EMAB utilizes patterned electrodes at the bottom of cell-sized microwells to trap single cells using dielectrophoresis (DEP) and cell-holding structures behind the microwells to stabilize the position of trapped cells even without DEP. Using the device, we evaluated the performance of p16/Ki67 dual immunostaining of HeLa cells on the chip. The device shows 98% cell-trapping efficiency as well as 92% cell-holding efficiency against the fixed HeLa cells, and we successfully demonstrated high-efficiency on-chip immunofluorescence analysis with minimal loss of sample. p16/Ki67 dual immunostaining using EMAB may be useful for complementary tests for cervical screening in confirming the histopathological diagnosis.

Identifiers

PMID31431817
PMCPMC6697034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.